Abstract
The general concept of hypnotic drugs is a vague one. Hypnotics alter the function of many parts of the brain which results not only in the more rapid onset and persistence of sleep, but changes in levels of consciousness, arousability, and mood, as well as in cognitive and motor function. Furthermore, most hypnotics have been subject to abuse, induce tolerance, and produce or satisfy dependencies. In general, hypnotics are used to treat patients who complain of sleep disorders which are commonly associated with discomforting anxieties or emotional and psychic trauma. Thus, the treatment of sleep disorders cannot be dissociated from the treatment of anxiety and affective disorders. Approximately one-fifth to one-third of the general population has sleep disorders (Bixler et al., 1976). At one time or another, 85% of patients complaining of sleep disorders have psychopathology as indicated by abnormal Minnesota Multiphasic Personality Inventory (MMPI) profiles (Kales and Kales, 1974).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdulian, D.H., Martin, W.R., Unna, K.R.: Effects of central nervous system depressants on inhibition and facilitation of the patellar reflex. Arch. Int. Pharmacodyn. 128, 169–186 (1960)
Adams, P.R.: Drug blockade of open end-plate channels. J. Physiol. (Lond.) 260, 531–552 (1976)
Arduini, A., Arduini, M.G.: Effects of drugs and metabolic alterations on brain stem arousal mechanism. J. Pharmacol. Exp. Ther. 110, 76–85 (1954)
Aston, R.: Quantitative aspects of tolerance and posttolerance hypersensitivity to pentobarbital in the rat. J. Pharmacol. Exp. Ther. 150, 253–258 (1965)
Banna, J.R., Jabbur, S.J.: Pharmacological studies on inhibition in the cuneate nucleus of the cat. Int. J. Neuropharmacol. 8, 299–307 (1969)
Bixler, E.O., Kales, J.D., Scharf, M.B., Kales A., Leo, L.: Incidence of sleep disorders in medical practice. A physicians survey. Sleep Res. 5, 160 (1976)
Blaustein, M.P., Ector, A.C.: Barbiturate inhibition of calcium uptake by depolarized nerve terminals in vitro. Molec. Pharmacol. 1975 II, 369–378
Bloedel, J.R., Roberts, W.J.: Functional relationship among neurons of the cerebellar cortex in the absence of anesthesia. J. Neurophysiol. 32, 75–84 (1969)
Boisse, NR., Okamoto, M.: Physical dependence to barbital compared to pentobarbital, III Withdrawal characteristics. J. Pharmacol. Exp. Ther. 204, 514 — 525 (1978)
Brazier, M.A.B.: The Electrophysiological Effects of Barbiturates on the Brain, In: Physiological pharmacology. Root, W.S., Hoffman, W.G. (eds.), pp. 219–238. Academic Press: New York 1963
Brooks, C. MC., Eccles, J.C.: Electrical investigations of the monosynaptic pathway through the spinal cord. J. Neurophysiol. 10, 251–273 (1947)
Brown, C.R., Forrest, W.H. and Hayden, J.: The respiratory effects of pentobarbital and secobarbital in clinical doses. J. Clin. Pharmacol. 13, 28–35 (1973)
Buch, H., Grund, J., Buzello, W. and Rummel, W.: Narkotische Wirksamkeit und Gewebsver- teilung der optischen Antipoden des Pentobarbital bei der Ratte. Biochem. Pharmacol. 18, 1005–1009 (1969)
Buch, H., Knabe, J., Bruzello, W., Rummel, W.: Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. J. Pharmacol. Exp. Ther. 175, 709–716 (1970)
Catchlove, R.F.H., Krnjevic, K., Maretic, H.: Similarity between effects of general anestethics and dinitrophenol on cortical neurones. Can. Physiol. Pharmacol. 50, 111–114 (1972)
Christensen, H.D., Lee, I.S.: Anesthetic potency and acute toxicity of optically active disubsti- tuted barbituric acids. Toxicol. App. Pharmacol. 26, 495–503 (1973)
Crawford, J.M.: Anesthetic agents and the chemical sensitivity of cortical neurones. Neuro-pharmacology P, 31–46 (1970)
Crawford, J.M., and Curtis, D. R.: Pharmacologic studies of feline Betz cells. J. Physiol. (Lond.) 186, 121–138 (1966)
Crossland, J., Leonard, B.E.: Barbiturate withdrawal convulsions in the rat. Biochem. Pharmacol. Suppl. 72, 103 (1963)
Dawn Quarterly Report: A report from the drug abuse warning network; April-June, 1978; U.S. Dept. of Justice, D.E.A. and U.S. Dept. of H.E.W., NIDA Dement, W.C.: The effect of dream deprivation. Science, 131, 1705–1707 (1960)
Deneau, G.A., Weiss, S.: A substitution technique for determining barbiturate-like physiological dependence capacity in the dog. Pharmakopsychiatr. Neuropsychopharmakol. 7, 270- 275 (1968)
Domino, E.F.: A pharmacological analysis of the functional relationship between the brainstem arousal and diffuse thalamic projection systems. J. Pharmacol. Exp. Ther. 775, 449- 463 (1955)
Domino, E.F.: Sites of action of some central nervous system depressants. Annu. Rev. Pharmacol. 2, 215–250 (1962)
Eccles, J.C.: Synaptic potentials of motoneurones. J. Neurophysiol. 9, 87–120 (1946)
Eccles, J.C., Malcolm, J.L.: Dorsal root potentials of the spinal cord. J. Neurophysiol. 9, 139- 160 (1946)
Eccles, J.C., Schmidt, R., Willis, W.D.: Pharmacological studies on presynaptic inhibition. J. Physiol. (Lond.), 168, 500–530 (1963)
Enna, S.J., Snyder, S.H.: GABA receptor binding in frog spinal cord and brain. J. Neurochem. 28, 857–860 (1977)
Esplin, D.W.: Criteria for assessing effects of depressant drugs on spinal cord synaptic transmission with examples of drug selectivity. Arch. Int. Pharmacodyn. Ther. 143, 479–497 (1963)
Essig, C.F.: Convulsive and sham rage behaviors in decorticate dogs during barbiturate withdrawal. Arch. Neurol. 7, 471–475 (1962a)
Essig, C.F.: Focal convulsions during barbiturate abstinence in dogs with cerebrocortical lesions. Psychopharmacology 3, 432–437 (1962b)
Essig, C.F.: Barbiturate withdrawal in white rats. Int. J. Neuropharmacol. 5, 103–107 (1966)
Essig, C.F., Flanary, H.G.: Convulsive aspects of barbital sodium withdrawal in the cat. Exp. Neurol. 3, 149–159 (1961)
Fraser, H.F., Isbell, H.: Abstinence syndrome in dogs after chronic barbiturate medication. J. Pharmacol. Exp. Ther. 772, 261–267 (1954)
Fraser, H.F., Jasinski, D.R.: The assessment of the abuse potentiality of sedative hypnotics (depressants). (Methods used in animals and man). In: Drug addiction I. Martin, W.R. (ed.), pp. 589–612. Berlin, Heidelberg, New York: Springer 1977
Fraser, H.F., Isbell, H., Eisenman, A.J., Wikler, A., Pescor, F.T.: Chronic barbiturate intoxication; further study. Arch. Int. Med. 94, 34–41 (1954)
Fraser, H.F., Wikler, A., Essig, C.F.: Degree of physical dependence induced by secobarbital or pentobarbital. J. Am. Med. Assoc. 166, 126–229 (1958)
Freudenthal, R.I., Martin, J.: Correlation of brain levels of barbiturate enantiomers with reported differences in duration of sleep. J. Pharmacol. Exp. Ther. 193, 664–668 (1975)
Furner, R.L., McCarthy, J.S., Stitzel, R.E., Anders, M.W.: Stereoselective metabolism of the enantiomers of hexobarbital. J. Pharmacol. Exp. Ther. 169, 153–158 (1969)
Galindo, A.: Effects of procaine, pentobarbital and halothane on synaptic transmission in the central nervous system. J. Pharmacol. Exp. Ther. 169, 185–195 (1969)
Gogalak, G.: Die Wirkung von Pentobarbital auf die Zelltatigkeit des Nucleus Ruber. Naunyn- Schmiedebergs Arch. Pharmak. 267, 249–264 (1970)
Gogalak, G., Stumpf, C.: Action of anesthetics on the firing pattern of nucleus ruber neurons. Naunyn-Schmiedebergs Arch. Pharmacol. 272, 387–394 (1972)
Gogalak, G., Liebeswar, G., Stumpf, C., Williams, H.L.: The relationship between barbiturate- induced activities in the cerebellum and red nucleus of the rabbit. Electroencephalogr. Clin. Neurophysicol. 29, 67–73 (1970)
Gogalak, G., Krijzer, F., Stumpf, C.: Action of central depressant drugs on the electrocerebel- logram of the rabbit. Naunyn-Schmiedebergs Arch. Pharmacol. 272, 378–386 (1972)
Gogerty, J.H.: Preclinical methodologies related to the development of hypnotic substances. In: Pharmacology of sleep. Williams, R.L., Karacan, I. (eds.), pp. 33–52. New York: John Wiley & Sons 1976
Gruner, J., Krieglstein, J., Rieger, H.: Comparison of the effects of chloral hydrate and trichlorethanol on the EEG of the isolated perfused rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 277, 333–348 (1973)
Hagbarth, K.E., Kerr, D.F.B.: Central influences on spinal afferent conduction. J. Neuro- physiol. 77, 295–307 (1954)
Haley, T.J., Gidley, J.T.: Pharmacological comparison of R(+), S(—) and racemic secobarbital in mice. Eur. J. Pharmacol. 9, 358–361 (1970)
Hartmann, E., Cravens, J.: The effects of long term administration of psychotropic drugs on human sleep: The effects of chloral hydrate. Psychopharmacology 33, 233–245 (1975)
Haycock, J.W., Levy, W.B., Cotman, Carl W.: Pentobarbital depression of stimulus-secretion coupling in brain. Selective inhibition of depolarization-induced calcium-dependent release. Chem. Pharmacol. 26, 159–161 (1977)
Hernandez-Peon, R., Scherrer, H.: Inhibitory influence of brain stem reticular formation upon synaptic transmission in trigeminal nucleus. Fed. Proc. 14, 71 (1955)
Himmelsbach, C.K.: Clinical studies of drug addiction II “Rossium” treatment of drug addiction. Publ. Hlth. Rp. (Wash.), Suppl. 125 (1937)
Houde, R.W., Wikler, A.: Delineation of the skin twitch response in dogs and the effects thereon of morphine, thiopental and mephenesin. J. Pharmacol. Exp. Ther. 103, 236–242 (1951)
Houde, R.W., Wikler, A., Irwin, S.: Comparative actions of analgesic, hypnotic and paralytic agents on hindlimb reflexes in chronic spinal dogs. J. Pharmacol. Exp. Ther. 103, 243–248 (1951)
Hug, C.E.: Characteristics and theories related to acute and chronic tolerance development. In: Chemical and biological aspects of drug dependence. Mule, S.J., Brill, H. (eds.), pp. 307- 358. Cleveland, Ohio: CRC Press 1972
Isbell, H., Fraser, H.F.: Addiction to analgesics and barbiturates. Pharmacol. Rev. 2, 355–397 (1950)
Isbell, H., Altschul, S., Kornetsky, C.H., Eisenman, E.J., Flanary, H.G., Fraser, H.F.: Chronic barbiturate intoxication; An experimental study. Arch. Neurol. Psychiatry 64, 1–28 (1950)
Jaffe, J.H., Sharpless, S.K.: The rapid development of physical dependence on barbiturates. J. Pharmacol. Exp. Ther. 150, 140–145 (1965)
Jasinski, D.R.: Assessment of the dependence liability of opiates and sedative-hypnotics. In: Psychic dependence: Definition, assessment in animals and man, theoretical and clinical implications. Goldberg, L., Hoffmeister, F. (eds.). Berlin, Heidelberg, New York: Springer 1973
Johnson, E.S., Roberts, M.H.T., Straughan, D.W.: The responses of cortical neurones to monoamines under differing anesthetic conditions. J. Physiol. (Lond.) 203, 261–280 (1969)
Johnston, L.D., Bachman, J.G., O’Malley, P.M.: Drugs and the Class of’78: Behaviors, atti-tudes and recent national trends. DHEW Publication No. (ADM) 79–877 (1979)
Jones, B.E., Prada, J.A., Martin, W.R.: A method for bioassay of physical dependence on sedative drugs in dog. Psychopharmacology 47, 7–15 (1976)
Jouvet, M.: Biogenic amines and the states of sleep. Science 163, 32–41 (1969)
Jovanovic, U.J.: Zum Problem der Effekte zentral-wirkender Pharmaka auf den REM-Anteil des Schlafs. Fortschr. Med. 92, 1090–1094 (1974)
Kalant, H., Leblanc, A.E., Gibbins, R.J.: Tolerance to and dependence on some non-opiate psychotropic drugs. Pharmacol. Rev. 23, 135–191 (1971)
Kales, A., Kales, J.D.: Sleep disorders. Recent findings in the diagnosis and treatment of disturbed sleep. New Engl. J. Med. 290, 487–499 (1974)
Kales, A., Allen, C., Scharf, M.B., Kales, J.D.: Hypnotic drugs and their effectiveness. III. All- night EEG studies of insomniac subjects. Arch. Gen. Psychiatry 23, 226–232 (1970a)
Kales, A., Kales, J.D., Scharf, M.B., Tan, T.L.: Hypnotics and altered sleep-dream patterns. II. All night EEG studies of chloral hydrate, flurazepam and methaqualone. Arch. Gen. Psychiatry 23, 219–225 (1970b)
Kales, A., Bixler, E.O., Leo, L.A., Healy, S., Slye, T.: Incidence of insomnia in the Los Angeles metropolitan area. Sleep Res. 3, 139 (1974)
Kales, A., Kales, J.D., Bixler, E.O., Scharf, M.B.: Effectiveness of hypnotic drugs with prolonged use: Flurazepam and pentobarbital. Clin. Pharmacol. Ther. 18, 356–363 (1975)
Kay, D.C., Jasinski, D.R., Eisenstein, R.B., Kelly, O.A.: Quantified human sleep after pentobarbital. Clin. Pharmacol. Ther. 13, 221–231 (1972)
Kay, D.C., Blackgurn, A.B., Buckingham, J.A., Karacan, I.: Human pharmacology of sleep. In: Pharmacology of sleep, Williams, R.L., Karacan, I. (eds.). New York: John L. Wiley 1976
Kety, S.S., Evarts, E.V., Williams, H.L.: Sleep and altered states of consciousness, Proceedings of the Association December 3 and 4, 1965,
New York. In: Res. Publ. Ass. Nerv. Ment. Dis., vol.XLV, Baltimore: Williams and Wilkins Co. 1967
Killam, E.K.: Drug action on the brain stem reticular formation. Pharmacol. Rev. 14, 175–223 (1962)
Killam, K.F., Killam, E.K.: Drug action on pathways involving the reticular formation. In: Reticular formation of the brain. Jasper, H.H., Proctor, L.D., Knighton, R.S., Noshay, W.C., Costello, R.T. (eds.), pp. 111–122. Boston: Little Brown and Co. 1958
King, E.E.: Differential action of anesthetics and interneuron depressants upon EEG arousal and recruitment responses. J. Pharmacol. Exp. Ther. 116, 404–417 (1956)
King, E.E., Naquet, R., Magoun, H.W.: Alterations in somatic afferent transmission through the thalamus by central mechanisms and barbiturates. J. Pharmacol. Exp. Ther. 119, 48–63 (1957)
Kitahata, L.M., Ghazi-Saidi, K., Yamashita, M., Kosaka, Y., Bonikos, C., Taub, A.: The depressant effect of halothane and sodium thiopental on the spontaneous and evoked activity of dorsal horn cells: lamina specificity time course and dose dependence. J. Pharmacol. Exp. Ther. 195, 515–521 (1975)
Krueger, J.M., Pappenheimer, J.R., Karnovsky, M.L.: Sleep-promoting factors: Purification and properties. Proc. Natl. Acad. Sei. USA 75, 5235–5238 (1978)
Larrabee, M.G., Posternak, J.M.: Selective action of anesthetics on synapses and axons in mammalian sympathetic ganglia. J. Neurophysiol. 15, 91–114 (1952)
Larson, M.D., Major, M.A.: The effect of hexobarbital on the duration of the recurrent IPSP in cat motoneurons. Brain Res. 21, 309–311 (1970)
Latham, A., Paul, D.H.: Effects of sodium thiopentone on cerebellar neurone activity. Brain Res. 25, 212–215 (1972)
Leblanc, A.E., Cappell, H.D.: Historical antecedents as determinants of tolerance to and dependence upon psychoactive drugs. In: Biologic and behavioral approaches to drug dependence. Cappell, H.D., LeBlanc, A.E. (eds.), pp. 43–51. Toronto Ontario: Addiction Research Foundation, House of Lind 1975
Lehmann, H.E., Ban, T.A.: The effects of hypnotics on rapid eye movement (REM). Int. Zeit. Klin. Pharmakol. Ther. Toxik. 1, 424–427 (1968)
Levin, P., Koella, W.P.: Sleep 1974. Instinct, neurophysiology, endocrinology, episodes, dreams, epilepsy and intracranial pathology. Proceedings of the Second European Congress on Sleep Research, Rome, April 8–11, 1974. Basel: S. Karger AG 1975
Light, D.B., Torrance, E.G.: Opium addiction VI. The effects of abrupt withdrawal followed by administration of morphine in human addicts with special reference to the composition of the blood, the circulation and metabolism. Arch. Intern. Med. 44, 1–16 (1929)
Ldyning, Y., Oshima, T., Yokota, T.: Site of action of thiamylal sodium on the monosynaptic spinal reflex pathway in cats. J. Neurophysiol. 27, 408–427 (1964)
Mangold, R., Sokoloff, L., Conner, E., Kleinerman, J., Therman, P.G., Kety, S.S.: The effect of sleep and lack of sleep on the cerebral circulation and metabolism of normal young men. J. Clin. Invest. 34, 1092–1100 (1955).
Martin, W.R., Eades, C.G.: A comparative study of the effect of drugs on activating and vasomotor responses evoked by midbrain stimulation: atropine, pentobarbital, chlor- promazine and chlorpromazine sulfoxide. Psychopharmacology 7, 303–335 (1960)
Martin, W.R., Gorodetzky, C.W.: Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). J. Pharmacol. Exp. Ther. 150, 437–442 (1965)
Martin, W.R., Fraser, H.F., Gorodetzky, C.W., Rosenberg, D.E.: Studies of the dependence- producing potential of the narcotic antagonist 2-cyclopropylmethyl-2-hydroxy-5,9-di- methyl-6, 7-benzomorphan (cyclazocine, Win 20, 740, ARC II-C-3). J. Pharmacol. Exp. Ther. 150, 426–436 (1965)
Martin, W.R., Thompson, W.O., Fraser, H.F.: Comparison of graded single intramuscular doses of morphine and pentobarbital in man. Clin. Pharmacol. Ther. 75, 623–630 (1974)
McClane, T.K., Martin, W.R.: Subjective and physiologic effects of morphine, pentobarbital and meprobamate. Clin. Pharmacol. Ther. 20, 192–198 (1976)
Mellinger, G.D., Baiter, M.B., Parry, H.J., Manheimer, D.J., Cisin, I.H.: An overview of psy-chotherapeutic drug use in the United States: Presented at Epidemiology of Drug Abuse Conference, San Juan, Puerto Rico, 1973
Miyahara, J.T., Esplin, D.W., Zablocka, B.: Differential effects of depressant drugs on presynaptic inhibition. J. Pharmacol. Exp. Ther. 154, 119–127 (1966)
Monnier, M., Hosli, L.: Dialysis of sleep and waking factors in blood of the rabbit. Science 146, 796–798 (1964)
Monnier, M., Schoenenberger, G.A., Dudler, L., Herkert, B.: Production isolation and further characterization of the “sleep peptide delta.” Biological aspects. In: Sleep, 1974. Instinct, neurophysiology, endocrinology, episodes, dreams, epilepsy and intracranial pathology. Levin, P., Koella, W.P. (eds.), Proceedings of the Second European Congress on Sleep Research, Rome, April 8–11, 1974. Basel: S. Karger AG 1975
Moruzzi, G., Magoun, H.W.: Brain stem reticular formation and activation of the EEG. Elec- troencephalogr. Clin. Neurophysiol. 7, 455–473 (1949)
Muller, W.E., Schlafer, V., Wollert, V.: Benzodiazepine receptor binding in rat spinal cord membranes. Neurosci. Lett. 9, 239–243 (1978)
Murphy, J.T., Sabah, N.H.: Spontaneous firing of cerebellar perkinje cells in decerebrated and barbiturate anesthetized cats. Brain Res. 77, 515–519 (1970)
Nagasaki, H., Iriki, M., Inoue, S., Uchizono, K.: The presence of sleep promoting material in the brain of sleep deprived rats. Proc. Jpn. Acad. 50, 241–246 (1974)
Ngai, S.A., Tseng, D.T.C., Wang, S.C.: Effect of diazepam and other central nervous system depressants on spinal reflexes in cats. A study of the site of action. J. Pharmacol. Exp. Ther. 153, 344–351 (1966)
Nicoll, R.A.: The effects of anesthetics on synaptic excitation and inhibition in the olfactory bulb. J. Physiol. (Lond.) 223, 803–814 (1972)
Nicoll, R.A.: Presynaptic actions of barbiturates in the frog spinal cord. Proc. Natl. Acad. Sci. USA 72, 1460–1463 (1975)
Nicoll, R.A.: Selective actions of barbiturates on synaptic transmission. In: Psychopharmacology: a generation of progress. Lipton, M.A., DiMascio, A., Killam, K.F. (eds.). New York: Raven Press 1978
Nicoll, R.A., Iwamoto, E.T.: Action of pentobarbital on sympathetic ganglion cells, J. Neurophysiol. 41, 977–986 (1978)
Nicoll, R.A., Eccles, J.C., Oshima, T., Rubia, F.: Prolongation of hippocampal in inhibitory potsynaptic potentials by barbiturates. Nature 258, 625–627 (1975)
Ogunremi, O.O., Adamson, L., Brezinova, V., Hunter, W.M., Maclean, A.W., Oswald, I., Percy-Robb, I.W.: Two anti-anxiety drugs: A psychoneuroendocrine study. Br. Med. J. 1973 II, 202–205
Okamoto, M., Rosenberg, H.C., Boisse, N.R.: Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat. J. Pharmacol. Exp. Ther. 192, 555–564 (1975)
Okamoto, M., Rosenberg, H.C., Boisse, N.R.: Withdrawal characteristics following chronic pentobarbital dosing in cat. Eur. J. Pharmacol. 40, 107–119 (1976)
Olsen, R.W., Greenlee, D., Vanness, P., Ticku, M.K.: Studies on the Gamma-aminobutyric acid receptor ionophore protein in mammalian brain. In: Amino acids as chemical transmitter. Fonnum, F. (ed.). New York, London: Plenum Press 1977
Pappenheimer, J.R., Fencl, V., Karnovsky, M.L., Koski, G.: Peptides in cerebrospinal fluid and their relation to sleep and activity. Brain dysfunction in metabolic disorders. F. Plum (ed.). Res. Publ. Assoc. Res. Nerv. Ment. Dis. 53, 201–210 (1974)
Pappenheimer, J.R., Koski, G., Fencl, V., Karnovsky, M.L., Krueger, J.: Extraction of sleep- promoting factors from cerebrospinal fluid and from brains of sleep-deprived animals. J. Neurophysiol. 38, 1299–1311 (1975)
Parry, H.J., Baiter, M.B., Mellinger, G.D., Cisin, I.H., Manhiemer, M.A.: National patterns of psychotherapeutic drug use. Arch. Gen. Psychiatry 28, 769–783 (1973)
Phillis, J.W., Tebecis, A.K.: The effects of pentobarbitone sodium on acetylcholine excitation and noradrenaline inhibition of thalamic neurons. Life Sci. 6, 1621–1625 (1967)
Pohlisch, K., Panse, F.: Schlafmittelmißbrauch. Leipzig: Georg Thieme 1934
Pole, P., Haefely, W.: Effects of two benzodiazepines, phenobarbitone and baclofen on synaptic transmission in the cat cuneate nucleus. Naunyn Schmiedebergs Arch. Pharmacol. 294, 121–131 (1976)
Ramm, P.: The locus coeruleus, catecholamines, and REM sleep: A critical review. Behav. Neur. Biol. 25, 415–448 (1979)
Ransom, B.R., Barker, J.L.: Pentobarbital modulates transmitter effects on mouse spinal neurones grown in tissue culture. Nature (Lond.) 254, 703–705 (1975)
Rashbass, C., Russell, C.F.M.: Action of a barbiturate drug (amylobarbitone sodium) on the vestibulo-ocular reflex. Brain 84, 329–335 (1961)
Richards, C.D.: On mechanism of barbiturate anesthesia. J. Physiol. (Lond.) 227, 749–767 (1972)
Rosenberg, H.C., Okamoto, M.: A method for producing maximal pentobarbital dependence in cats: dependency characteristics. In: Drug addiction: Neurobiology and influences on be-havior. Singh, J.M., Lai, H. (eds.), vol. 3. Miami: Miami’s Symposium Specialists 1974
Rosenberg, H.C., Okamoto, M.: Electrophysiology of barbiturate withdrawal in the spinal cord. J. Pharmacol. Exp. Ther. 199, 189–197 (1976)
Schmidt, R.F.: Pharmacological studies on the primary afferent depolarization of the toad spinal cord. Pfluegers Arch. 277, 325–346 (1963)
Schmidt, H., Kleinman, K.M.: Effect of chronic administration and withdrawal of barbiturates upon drinking in the rat. Arch. Int. Pharmacodyn. Ther. 151, 142–149 (1964)
Schofleld, C.N.: A barbiturate induced intensification of the inhibitory potential of guinea pig olfactory cortex. J. Physiol. (Lond.) 275, 559–566 (1978)
Scholfield, C.N., Harvey, J.A.: Local anesthetics and barbiturates: Effects in evoked potentials in isolated mammalian cortex. J. Pharmacol. Exp. Ther. 195, 522–531 (1975)
Seevers, M.H., Tatum, A.L.: Chronic experimental barbital poisoning. J. Pharmacol. Exp. Ther. 42, 217–231 (1931)
Seyama, I., Narahashi, T.: Mechanism of blockade of neuromuscular transmission by pentobarbital. J. Pharmacol. Exp. Ther. 192, 95–104 (1975)
Shapovalov, A.I.: Intracellular microelectrode investigation of effects of anesthetics on transmission of excitation in the spinal cord. Fed. Proc. 23, T113 — T116 (1963)
Smaje, J.C.: General anesthetics and the acetylcholine-sensitivity cortical neurons. Br. J. Pharmacol. 58, 359–366 (1976)
Smith, C.M.: The pharmacology of sedative/hypnotics, alcohol and anesthetics: Sites and mechanisms of action. In: Drug addiction I. Martin, W.R. (ed.). Berlin, Heidelberg, New York: Springer 1977
Soldatos, C.R., Kales, A., Kales, J.D.: Management of insomnia. Annu. Rev. Med. 30, 301–312 (1979)
Somjen, G.G.: Effects of ether and thiopental on spinal presynaptic terminals. J. Pharmacol. Exp. Ther. 140, 396–402 (1963)
Somjen, G.G., Gill, M.: The mechanism of blockade of synaptic transmission in the mammalian spinal cord by diethylether and by thiopental. J. Pharmacol. Exp. Ther. 140, 19–30 (1963)
Stevenson, I.H., Turnbull, M.J.: The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat. Brit. J. Pharmacol. 39, 325–333 (1970)
Stevenson, I.H., Turnbull, M.J.: A study of the factors affecting the sleeping time following in- tracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally acting drugs. Brit. J. Pharmacol. 50, 499–511 (1974)
Ticku, M.K., Olsen, R.W.: Interaction of barbiturates with dihydropicrotoxinin binding sites related to the GABA receptor-ionophore system. Life Sci. 22, 1643–1651 (1978)
Tsuchiya, T., Fukushima, H.: Effects of benzodiazepines and pentobarbitone on the GABA- ergic recurrent inhibition of hippocampal neurones. Eur. J. Pharmacol. 48, 421–424 (1978)
Turnbull, M.J., Watkins, J.W.: Acute tolerance to barbiturates in the rat. Eur. J. Pharmacol. 36, 15–20 (1976)
Waddell, W.J., Baggett, B.: Anesthetic and lethal activity in mice of the stereoisomers of 5- ethyl-5-(l-methylbutyl) barbituric acid (pentobarbital). Arch. Int. Pharmacodyn. Ther. 205, 40–44 (1973)
Wahlstrom, G.: Differences in anesthetic properties between the optical antipodes of hexobar- bital in the rat. Life Sci. 5, 1781–1790 (1966)
Wahlstrom, G.: The interaction between spontaneous convulsions and tolerance to hexobarbi- tal in the abstinence after chronic barbital treatments in the rat. Life Sci. 19, 1817–1826 (1976a)
Wahlstrom, G.: The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatment in the cat. Psychopharmacology 48,239- 245 (1976b)
Weakly, J.N.: Effect of barbiturates on “quantal” synaptic transmission in spinal mon- toneurones. J. Physiol. (Lond.) 204, 63–77 (1969)
Weitzman, E.D. (ed.): Advances in sleep research, Vol. 1. Flushing: Spectrum Publications, Inc. 1974
Wikler, A.: Effects of morphine, nembutal, ether and eserine in two-neuron and multineuron reflexes in the cat. Proc. Soc. Exp. Biol. Med. 58, 193–196 (1945)
Williams, R.L., Karacan, I.: Pharmacology of sleep. New York: John Wiley & Sons 1976
Wolf, P., Haas, H.L.: Effects of diazepines and barbiturates on hippocampal recurrent inhibition. Naunyn-Schmiedebergs Arch. Pharmacol. 299, 211–218 (1977)
Yanagita, T., Takahashi, S.: Development of tolerance to and physical dependence on barbiturates in rhesus monkeys. J. Pharmacol. Exp. Ther. 172, 163–169 (1970)
Yanagita, T., Takahashi, S.: Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J. Pharmacol. Exp. Ther. 185, 307–316 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Martin, W.R. (1982). Hypnotics. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67770-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-67770-0_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67772-4
Online ISBN: 978-3-642-67770-0
eBook Packages: Springer Book Archive